即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.
CAS号 | 1000287-05-7 | 货号 | BCP44275 |
中文名 | TMC-310911 | ||
英文名 | TMC-310911 | ||
中文别名 | |||
英文别名 | ASC-09; TMC310911; ASC09; TMC 310911; ASC 09; | ||
SMILES | CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC5=C(C=C4)N=C(S5)NC6CCN(CC6)C7CCCC7 | ||
化学名称 | |||
分子式 | C38H53N5O7S2 | 分子量 | 755.99 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | TMC-310911 is a novel investigational protease inhibitor (PI) that is structurally similar to the currently available [darunavir]. It is being investigated for use in HIV-1 infections. TMC-310911 has shown marked activity against a variety of HIV-1 strains, including multi-PI-resistant strains, and may be less likely to generate resistance, making it a potentially desirable therapy for both treatment-naive and PI-experienced patients. TMC-310911 is currently being investigated, in combination with other HIV therapies and antivirals, as a potential treatment for COVID-19 caused by SARS-CoV-2. |
相关产品推荐
查看更多 >Tags:TMC-310911 供应商,TMC-310911 购买,TMC-310911 生产,TMC-310911 批量,TMC-310911 供应,TMC-310911 订购,TMC-310911 采购